ROY WINSTON Insider Trading $PCRX Pacira BioSciences, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROY WINSTON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROY WINSTON. ROY WINSTON is Chief Clinical Officer in Pacira BioSciences, Inc. ($PCRX).
ROY WINSTON in Pacira BioSciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROY WINSTON: Chief Clinical Officer
Holdings: 31,035 shares
Current Value: $1,295,711
Latest Transaction: Jun 11 2021
$PCRX Market Capitalization: $1.57B
$PCRX Previous Close: $41.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROY WINSTON in Pacira BioSciences, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11 2021 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Option Exercise | A | 60.96 | 17,500 | 1,066,800 | 17,500 | |
| Jun 11 2021 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Grant | A | 0.00 | 7,000 | 0 | 31,035 | 24 K to 31 K (+29.12 %) |
| Apr 02 2021 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Option Exercise | M | 34.38 | 13,750 | 472,656 | 6,250 | |
| Apr 02 2021 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Sell | S | 72.12 | 1,200 | 86,544 | 26,311 | 27.5 K to 26.3 K (-4.36 %) |
| Apr 02 2021 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Sell | S | 71.09 | 4,661 | 331,350 | 27,511 | 32.2 K to 27.5 K (-14.49 %) |
| Apr 02 2021 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Sell | S | 70.36 | 16,363 | 1,151,301 | 32,172 | 48.5 K to 32.2 K (-33.71 %) |
| Apr 02 2021 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Buy | M | 34.38 | 13,750 | 472,656 | 48,535 | 34.8 K to 48.5 K (+39.53 %) |
| Nov 17 2020 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Sell | S | 62.00 | 5,000 | 310,000 | 34,785 | 39.8 K to 34.8 K (-12.57 %) |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Option Exercise | A | 47.65 | 35,000 | 1,667,750 | 35,000 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Grant | A | 0.00 | 14,000 | 0 | 39,237 | 25.2 K to 39.2 K (+55.47 %) |
| Mar 12 2020 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Buy | P | 36.50 | 2,500 | 91,250 | 25,237 | 22.7 K to 25.2 K (+11.00 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Option Exercise | A | 43.54 | 33,800 | 1,471,652 | 33,800 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Grant | A | 0.00 | 5,600 | 0 | 22,139 | 16.5 K to 22.1 K (+33.86 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Sell | S | 42.91 | 722 | 30,981 | 16,539 | 17.3 K to 16.5 K (-4.18 %) |
Page: 1